Keurig Dr Pepper is trading at $34.69, down 5.80%, after management reaffirmed, rather than raised, its full-year outlook.
- November 3, 2026 results beat earnings and revenue expectations.
- Management reaffirmed 2026 sales guidance of $25.9–$26.4 billion and low-double-digit adjusted EPS growth.
- Reuters reported quarterly gross margin fell to 48% from 54.3%, citing inflation and higher marketing expenses, and noted revised expectations for legacy U.S. Coffee; defensive-sector strength is not offsetting the decline.